Marinella Clerico
University of Turin
119 Papers
338 Citations
Marinella Clerico is an academic researcher from University of Turin. The author has contributed to research in topics: Medicine & Multiple sclerosis. The author has an hindex of 25, co-authored 89 publications.
Chat about Author
Papers
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.
Maria Pia Sormani,Matilde Inglese,Irene Schiavetti,Luca Carmisciano,Alice Laroni,Caterina Lapucci,Giorgio Da Rin,Carlo Serrati,Ilaria Gandoglia,Tiziana Tassinari,Germana Perego,Giampaolo Brichetto,Paola Gazzola,Antonio Mannironi,Maria Laura Stromillo,Cinzia Cordioli,Doriana Landi,Marinella Clerico,Elisabetta Signoriello,Jessica Frau,Maria Teresa Ferrò,Alessia Di Sapio,Livia Pasquali,Monica Ulivelli,Fabiana Marinelli,Graziella Callari,Rosa Iodice,Giuseppe Liberatore,Francesca Caleri,Anna Maria Repice,Susanna Cordera,Mario Alberto Battaglia,Mario Alberto Battaglia,Marco Salvetti,Diego Franciotta,Antonio Uccelli,Alessandro Maglione,Alessio Signori,Aniello Iovino,Carolina Gabri Nicoletti,Chiara Rosa Mancinelli,Daiana Bezzini,Daniele Carmagnini,Davide Brogi,Eduardo Nobile Orazio,Eleonora Cocco,Enri Nako,Ester Assandri,Federica Baldi,Filippo Ansaldi,Francesca Bovis,Gabriele Siciliano,Gaia Cola,Giacomo Lus,Giancarlo Icardi,gianmarco bellucci,Girolama Alessandra Marfia,Giulia Vazzoler,Giuseppe Trivelli,Ilaria Maietta,Laura Sticchi,Lorena Lorefice,Lucia Ruggiero,Marcello Manzino,Margherita Monti Bragadin,Maria Chiara Buscarinu,Maria Gagliardi,Maria Teresa Rilla,Marta Ponzano,Marzia Fronza,Massimo Del Sette,Matteo Scialabba,Michele Bedognetti,Nicola De Rossi,Nicola De Stefano,Rachele Bigi,Raffaele Dubbioso,Roberta Reniè,Sabrina Fabbri,Sarah Rasia,Simona Rolla,Stefan Platzgummer,Valentina Carlini +82 more
TL;DR: In this article, a prospective multicenter cohort study was designed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response in patients with Multiple Sclerosis (pwMS).
213
Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies
Maria Pia Sormani,Matilde Inglese,Irene Schiavetti,Luca Carmisciano,Alice Laroni,Caterina Lapucci,Giorgio Da Rin,Carlo Serrati,Ilaria Gandoglia,Tiziana Tassinari,Germana Perego,Giampaolo Brichetto,Paola Gazzola,Antonio Mannironi,Maria Laura Stromillo,Cinzia Cordioli,Doriana Landi,Marinella Clerico,Elisabetta Signoriello,Jessica Frau,Maria Teresa Ferrò,Alessia Di Sapio,Livia Pasquali,Monica Ulivelli,Fabiana Marinelli,Graziella Callari,Rosa Iodice,Giuseppe Liberatore,Francesca Caleri,Anna Maria Repice,Susanna Cordera,Mario Alberto Battaglia,Marco Salvetti,Diego Franciotta,Antonio Uccelli +34 more
TL;DR: In pwMS, therapy with anti-CD20 and fingolimod led to a reduced humoral response to SARS-CoV-2 vaccines, and mRNA-1273 vaccine resulted in a systematically 3·5-fold higher antibody level than the BNT162b2 vaccine.
168
Epigenetic therapy for Friedreich ataxia
Elisabetta Soragni,Wenyan Miao,Marco Iudicello,David Jacoby,Stefania Federica De Mercanti,Marinella Clerico,Filomena Longo,Antonio Piga,Sherman Ku,Erica Campau,Jintang Du,Pablo Penalver,Myriam Rai,Joseph C. Madara,Kristopher L. Nazor,Melinda O'Connor,Anton Maximov,Jeanne F. Loring,Massimo Pandolfo,L. Durelli,Joel M. Gottesfeld,James R. Rusche +21 more
TL;DR: To investigate whether a histone deacetylase inhibitor (HDACi) would be effective in an in vitro model for the neurodegenerative disease Friedreich ataxia and to evaluate safety and surrogate markers of efficacy in a phase I clinical trial in patients.
•Journal Article
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
Antonio Canosa,Cristina Moglia,Stefania Cammarosano,Giacomo Bovio,Edo Bottacchi,Letizia Mazzini,Fabrizio Pisano,Andrea Calvo,Adriano Chiò,Gabriele Mora,Roberto Cantello,Kalliopi Marinou,Stefania Federica De Mercanti,Antonio Ilardi,Enrica Bersano,Umberto Manera,Davide Bertuzzo,Riccardo Sideri,Paolo Cugnasco,Francesco Galmozzi,Marinella Clerico +20 more
TL;DR: In this article, the authors correlate several hematological markers evaluated at diagnosis with ALS outcome in a population-based series of patients (discovery cohort) and replicate the findings in an independent validation cohort from an ALS tertiary center.
109
Digital therapeutics in neurology.
Gianmarco Abbadessa,Francesco Brigo,Marinella Clerico,S. De Mercanti,Francesca Trojsi,G. Tedeschi,Simona Bonavita,Luigi Lavorgna +7 more
TL;DR: Digital therapeutics (DTx) is a section of digital health defined by the DTx Alliance as "delivering evidence-based therapeutic interventions to patients that are driven by software to prevent, manage, or treat a medical disorder or disease".